Celularity Inc. (NASDAQ:CELU) stock surged Thursday after the company announced a U.S. manufacturing collaboration with MuseCell Innovations.
Under the agreement, Celularity will work to establish U.S. production of Dezawa MuseCells at its facility in Florham Park, New Jersey.
Deal Could Expand
The initial program will focus on authenticated cell preparations made from qualified perinatal, bone marrow or adipose materials. Celularity will use the licensed Dezawa Method and MuseCell’s product specifications.
The collaboration also covers products derived from the cells. These include Dezawa MuseExosomes and Dezawa MuseSecretome.
